The expansion of DeepSeek’s private capitalisation to between $12 Billion and $15 Billion at a valuation approaching $75 Billion, setting the stage for an initial public offering on the Shanghai stock exchange, marks a critical structural inflection in foundation model development and enterprise health informatics. Controlled by founder Liang Wenfeng, the enterprise has established a formidable counterweight to compute intensive Western artificial intelligence laboratories. S
Nelson Advisors
2 hours ago
Add a title here. Make it bold and impactful. Click to edit.
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.